(MRNA)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.56 (+3.63%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of (MRNA)

Historical Stock Splits

If you bought 1 share of MRNA before July 22, 2010, you'd have 0.00 shares today.
Execution DateSplit Amount
August 3, 20171-for-10 (Reverse Split)
December 23, 20111-for-10 (Reverse Split)
July 22, 20101-for-4 (Reverse Split)

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$1.95 Billion
Net Cash Flow From Operating Activities$-3.21 Billion
Net Cash Flow$-1.31 Billion
Net Cash Flow From Investing Activities$1.95 Billion
Net Cash Flow, Continuing$-1.31 Billion
Net Cash Flow From Operating Activities, Continuing$-3.21 Billion
Net Cash Flow From Financing Activities$-50.00 Million
Net Cash Flow From Financing Activities, Continuing$-50.00 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Diluted Earnings Per Share$5.82
Preferred Stock Dividends And Other Adjustments$0.00
Cost Of Revenue$1.65 Billion
Benefits Costs and Expenses$7.43 Billion
Operating Expenses$6.12 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Basic Earnings Per Share$5.82
Net Income/Loss Attributable To Parent$-2.22 Billion
Gross Profit$3.43 Billion
Revenues$5.08 Billion
Income/Loss From Continuing Operations Before Tax$-2.35 Billion
Income Tax Expense/Benefit$-129.00 Million
Income/Loss From Equity Method Investments$-62.00 Million
Income/Loss From Continuing Operations After Tax$-2.22 Billion
Operating Income/Loss$-2.69 Billion
Research and Development$4.83 Billion
Basic Average Shares$768.00 Million
Costs And Expenses$7.77 Billion
Diluted Average Shares$782.00 Million
Net Income/Loss Available To Common Stockholders, Basic$-2.22 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Other Operating Expenses$1.29 Billion
Income/Loss Before Equity Method Investments$-2.29 Billion
Net Income/Loss$-2.22 Billion

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Liabilities And Equity$15.80 Billion
Inventory$412.00 Million
Wages$244.00 Million
Equity$11.93 Billion
Noncurrent Assets$6.14 Billion
Other Current Assets$9.25 Billion
Noncurrent Liabilities$1.68 Billion
Liabilities$3.88 Billion
Equity Attributable To Noncontrolling Interest$0.00
Other Current Liabilities$1.58 Billion
Accounts Payable$373.00 Million
Current Assets$9.67 Billion
Current Liabilities$2.20 Billion
Assets$15.80 Billion
Equity Attributable To Parent$11.93 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to (MRNA)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.